Shifting to first-line regimen after previous failure of irinotecan and oxaliplatin containing chemotherapies in unresectable metastatic colorectal cancer: a retrospective study of case analysis

Case Analysis ◽

First Line ◽

First-Line Systemic Chemotherapy with Folfoxiri Followed by Radical Surgical Resection of Metastases for the Treatment of Unresectable Metastatic Colorectal Cancer Patients

Platinum and Other Heavy Metal Compounds in Cancer Chemotherapy ◽

10.1007/978-1-60327-459-3_32 ◽

2009 ◽

pp. 285-293

Author(s):

Enrico Vasile ◽

Gianluca Masi ◽

Fotios Loupakis ◽

Samanta Cupini ◽

Giacomo Giulio Baldi ◽

...

Keyword(s):

Colorectal Cancer ◽

Cancer Patients ◽

Surgical Resection ◽

Systemic Chemotherapy ◽

First Line ◽

Resection Of Metastases ◽

Colorectal Cancer Patients ◽

Radical Surgical Resection ◽

Patient‐reported symptom burden as a prognostic factor in treatment with first‐line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: Results of Phase II QUACK trial

Cancer Medicine ◽

10.1002/cam4.2826 ◽

2020 ◽

Vol 9 (5) ◽

pp. 1779-1789 ◽

Cited By ~ 2

Author(s):

Akira Ooki ◽

Satoshi Morita ◽

Shigeyoshi Iwamoto ◽

Hiroki Hara ◽

Hiroaki Tanioka ◽

...

Keyword(s):

Colorectal Cancer ◽

Prognostic Factor ◽

Phase Ii ◽

Symptom Burden ◽

First Line ◽

Patient Reported ◽

The prognostic significance of the advanced lung cancer inflammation index in patients with unresectable metastatic colorectal cancer: a retrospective study

BMC Cancer ◽

10.1186/s12885-019-5468-9 ◽

2019 ◽

Vol 19 (1) ◽

Cited By ~ 10

Author(s):

Masatsune Shibutani ◽

Kiyoshi Maeda ◽

Hisashi Nagahara ◽

Tatsunari Fukuoka ◽

Shinji Matsutani ◽

...

Keyword(s):

Colorectal Cancer ◽

Lung Cancer ◽

Retrospective Study ◽

Prognostic Significance ◽

Advanced Lung Cancer ◽

Cancer Inflammation ◽

P-4 The relationship between quality of life, adverse events, and treatment efficacy in treatment with first-line chemotherapy plus cetuximab for unresectable metastatic colorectal cancer: Results of phase II QUACK trial

Annals of Oncology ◽

10.1016/j.annonc.2020.04.086 ◽

2020 ◽

Vol 31 ◽

pp. S90

Author(s):

O. Akira ◽

S. Morita ◽

S. Iwamoto ◽

H. Hara ◽

H. Tanioka ◽

...

Keyword(s):

Quality Of Life ◽

Colorectal Cancer ◽

Adverse Events ◽

Treatment Efficacy ◽

First Line ◽

The Relationship ◽

Line Chemotherapy ◽

Effectiveness of Cetuximab as First-Line Therapy for Patients With Wild-Type KRAS and Unresectable Metastatic Colorectal Cancer in Real-Life Practice: Results of the EREBUS Cohort

Clinical Colorectal Cancer ◽

10.1016/j.clcc.2018.01.007 ◽

2018 ◽

Vol 17 (2) ◽

pp. 129-139 ◽

Cited By ~ 6

Author(s):

Magali Rouyer ◽

Eric François ◽

Antonio Sa Cunha ◽

Alain Monnereau ◽

Pernelle Noize ◽

...

Keyword(s):

Colorectal Cancer ◽

Real Life ◽

Wild Type ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Maintenance single-agent bevacizumab or observation after first-line chemotherapy in patients with metastatic colorectal cancer: a multicenter retrospective study

Investigational New Drugs ◽

10.1007/s10637-013-9936-9 ◽

2013 ◽

Vol 31 (4) ◽

pp. 1035-1043 ◽

Cited By ~ 8

Author(s):

Luca Moscetti ◽

Fabrizio Nelli ◽

Maria A Fabbri ◽

Isabella Sperduti ◽

Daniele Alesini ◽

...

Keyword(s):

Colorectal Cancer ◽

Retrospective Study ◽

Single Agent ◽

First Line ◽

Line Chemotherapy

FOLFOXIRI/Bevacizumab Versus FOLFIRI/Bevacizumab as First-Line Treatment in Unresectable Metastatic Colorectal Cancer: Results of Phase III Tribe Trial by Gono Group

Annals of Oncology ◽

10.1093/annonc/mdt201.26 ◽

2013 ◽

Vol 24 ◽

pp. iv21 ◽

Cited By ~ 4

Author(s):

Chiara Cremolini ◽

Fotios Loupakis ◽

Gianluca Masi ◽

Sara Lonardi ◽

Vittorina Zagonel ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Iii ◽

Line Treatment ◽

First Line ◽

First Line Treatment ◽

Efficacy of continued cetuximab for unresectable metastatic colorectal cancer after disease progression during first-line cetuximab-based chemotherapy: a retrospective cohort study

Oncotarget ◽

10.18632/oncotarget.7193 ◽

2016 ◽

Vol 7 (10) ◽

pp. 11380-11396 ◽

Cited By ~ 4

Author(s):

Qingyang Feng ◽

Ye Wei ◽

Li Ren ◽

Peng Zheng ◽

Yiyi Yu ◽

...

Keyword(s):

Colorectal Cancer ◽

Cohort Study ◽

Disease Progression ◽

Retrospective Cohort Study ◽

Retrospective Cohort ◽

First Line ◽

438P First line treatment patterns in BRAFV600E-mutant metastatic colorectal cancer patients (mCRC): The CAPSTAN European retrospective study

Annals of Oncology ◽

10.1016/j.annonc.2021.08.959 ◽

2021 ◽

Vol 32 ◽

pp. S553

Author(s):

B. Asselain ◽

E. Martinelli ◽

C. Cremolini ◽

T. Mazard ◽

J. Vidal ◽

...

Keyword(s):

Colorectal Cancer ◽

Retrospective Study ◽

Cancer Patients ◽

Treatment Patterns ◽

Line Treatment ◽

First Line ◽

Colorectal Cancer Patients ◽

First Line Treatment

P-9 A randomized study of panitumumab plus mFOLFOX6 compared with bevacizumab plus mFOLFOX6 as first-line treatment for unresectable metastatic colorectal cancer

Annals of Oncology ◽

10.1016/j.annonc.2020.04.091 ◽

2020 ◽

Vol 31 ◽

pp. S92

Author(s):

S. Belhadef ◽

A. Arab ◽

M. Belmadi ◽

M. Beninal ◽

N. Bacha ◽

...

Keyword(s):

Colorectal Cancer ◽

Randomized Study ◽

Line Treatment ◽

First Line ◽

First Line Treatment ◽